Why digital transformation is essential in the pharma supply chain
Keep up with developments in pharma supply chain visibility. Sign up for Controlant Insights and receive our latest white paper.
The Covid-19 pandemic exposed the weaknesses in global pharmaceutical supply chains when it caused governments to shut their borders and manufacturing plants to close. Existing problems such as shortages of generic drugs and logistical and regulatory challenges hindered the ability of many organizations to quickly recover from disruptions.